Evidence map›Paper›PMID 31801837›Full record

ArticleJournal of clinical microbiology2020

Multicentric Evaluation of the Bio-Evolution Toxoplasma gondii Assay for the Detection of

Nawel Ait Ammar, Hélène Yera, Jeanne Bigot, Françoise Botterel, Christophe Hennequin, Juliette Guitard

Abstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nawel Ait AmmarEA Dynamyc 7380 UPEC, ENVA, Faculté de Médecine de Créteil, Créteil, France.
Hélène YeraLaboratory of Parasitology-Mycology, Université Paris Descartes, AP-HP, Hôpitaux Universitaires Paris Centre, Hôpital Cochin, Paris, France.
Jeanne BigotCentre de Recherche Saint-Antoine, CRSA, AP-HP, Sorbonne Université, Inserm, Hôpital Saint-Antoine, Paris, France.
Françoise BotterelEA Dynamyc 7380 UPEC, ENVA, Faculté de Médecine de Créteil, Créteil, France.
Christophe HennequinCentre de Recherche Saint-Antoine, CRSA, AP-HP, Sorbonne Université, Inserm, Hôpital Saint-Antoine, Paris, France.
Juliette GuitardCentre de Recherche Saint-Antoine, CRSA, AP-HP, Sorbonne Université, Inserm, Hôpital Saint-Antoine, Paris, France juliette.guitard@aphp.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PCR-based methods are a key tool for the diagnosis of toxoplasmosis in immunocompromised patients. Laboratory-developed protocols lack standardization. This study aimed to assess the performances of a commercial kit for the detection of

Indexed as

Immunocompromised HostDNA, ProtozoanHumansMolecular Diagnostic TechniquesReagent Kits, DiagnosticReal-Time Polymerase Chain ReactionRetrospective StudiesSensitivity and SpecificityToxoplasmaToxoplasmosisDNA, ProtozoanReagent Kits, Diagnosticimmunocompromised patientsquantitative PCRtoxoplasmosis

Identifiers

PMID31801837
PMCPMC6989062

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.